CI vs SGMO · P/E 2.4, rev $274.90B vs rev $57.8M
Cigna Corp (CI) versus Sangamo Therapeutics Inc (SGMO) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SGMO currently screens at market cap $74.6M.
Not investment advice. Open the CI and SGMO stock pages for the full models.
Not investment advice.